Stemness‐associated biomarkers like SOX2, OCT4, Nanog, and increased ALDH activity are responsible for cancer stem cell self‐renew and differentiation and correlated with poor prognosis in pancreatic cancer patients.38 This evidence concerns the gene POU5F1 and cancer.